Clinical Trial Search

Primary: Estimated Mean Change in Weight From Baseline to 6 Months — -0.1; -0.2; -1.2 kg

Primary: False Positive Urine — 6; 40 Participants

Primary: Participation in Cardiac Rehabilitation — 231; 252 Participants — p=0.80

Primary: Number of Participants Meeting Patient-Caregiver Session and Care Plan Acceptability Criteria — 18; 18; 17; 15 participants

Primary: Change (Per Day) in Average Daily Steps From Baseline — 2.8; 2.9; -8.2; -1.2 Change (per day) in Average Daily Steps — p=0.973

Primary: the Safety Profile of CAP 1002; Any Subjects Experiencing Any Safety Related Events During or Post Intracoronary Delivery and During the Follow up Period. — 0; 1…

Primary: Change in Cardiovascular Disease Risk From Baseline to After Functional Cure of Hepatitis C, as Measured by High-sensitivity C-reactive Protein — 0.6; 0 mg/L

Primary: Mean Percent Body Weight (Pounds) Change — 0.88; 0.53; -1.06 percent weight change — p=0.1013

Primary: Number of Participants With Viral Load Suppression — 210; 213 Participants — p=0.220

Primary: Feasibility as Measured by Recruitment Rate — 8; 2 Participants

Primary: Correlation Coefficient for Accuracy of Test Device vs Reference Device — 0.99; 0.95 Correlation Coefficient

Primary: Cardiovascular Disease Risk Factors — 3; 4; 5; 7 participants

Primary: Child Behavior Problems — 132.8; 145.4 score on a scale

Primary: A1c (Laboratory Assessment) — 35; 35 Participants

Primary: Change in Intact FGF23 — 1.001; 1.006; 1.009; 1.005 pg/ml — p=0.3738

Primary: Percent Change in Body Weight — -0.15; -1.42 percentage of change — p=0.017

Primary: Percentage of Leukocyte Subsets Including B Lymphocytes, Classical B Lymphocytes, Double Negative B Lymphocytes, Naive B Lymphocytes, Plasmablast and Transitional B…

Primary: Number of Subjects Who Discussed Disease Risk With Primary Care Provider — 905; 841 Participants

Primary: Number of Participants Reporting Pediatric Symptoms as Assessed by the Pediatric Symptom Checklist-17 (PSC-17) — 3; 2; 4; 3 participants

Primary: Feasibility of the Diet Intervention — 4782 prescribed diet visits

Primary: Triglycerides — 199; 216.9; 155.1; 177.6 mg/dL

Primary: Dental Health Care Worker (DHCW) Willingness to Participate in the Study — 10 Participants

Primary: Left Ventricular Mass Index — 67; 60 g/m2 — p=0.27

Primary: Absolute Change in Relative FMD (%) — 0.60; 0.50 % FMD — p=0.28

Primary: Dietary Intake as Measured by Percent Energy From Fat — 33.75; 34.9; 33.72; 35.05 percent energy from fat — p=0.1073

Primary: Number of Subjects With an Adverse Event. — 1; 0; 0; 0 participants

Primary: Estimated Weekly Change on World Health Organization-5 (WHO-5) — 0.78; 0.76; 0.41; 0.33 estimated weekly change in scale score — p=.820

Primary: DEXA-measured Adiposity — 0.76; -0.43; -2.79 kilograms — p=0.01

Primary: Peak Oxygen Consumption — 3.07 ml/min/kg

Primary: Clinically Significant Difference in Blood Pressure Lowering, Health Status and Quality of Life — -3.3; -4.9 mm Hg